CHTI Health Tech Advisory Group Virtual Roundtable: Amplity & Brainomix

This virtual roundtable explores how the American Heart Association connects clinicians, scientists, and innovators to accelerate patient centered health technology. Featured Innovators: Amplity is a full-service commercialization partner to biopharma and their stakeholders. No matter where their partners are in their research or commercialization journeys, they deliver both flexible and specialized medical and commercial services rooted in innovation and focused on advancing healthcare. They scale with ease to maximize resources and improve impact. Their people-driven, tech-enabled, AI-centered DNA fuels everything they do. Brainomix is a global pioneer in AI medical imaging, enabling precision medicine for better treatment decisions in stroke and lung fibrosis. Founded as a spinout from the University of Oxford, the company has deep academic and scientific roots, and a relentless focus on evidence-based medicine. Its flagship product, Brainomix 360 Stroke, is the world's first fully automated AI-imaging platform, designed for acute stroke assessment at all points of the patient pathway, facilitating more confident treatment and transfer decisions for patients in all hospitals, regardless of local resources or expertise.